The Journal of clinical endocrinology and metabolism

publication venue for

Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab. 2018
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma. 2024
Approach to the Patient: Normocalcemic Primary Hyperparathyroidism. 2024
Developing a predictive model for metastatic potential in pancreatic neuroendocrine tumor. 2024
Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence. 2024
Opportunistic Evaluation of Trabecular Bone Texture by MRI Reflects Bone Mineral Density and Microarchitecture.. 108. 2023
Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma? 2023
Five-year weight loss maintenance with obesity pharmacotherapy. 2023
Treatment of Cushing Disease With Pituitary-Targeting Seliciclib.. 108. 2023
Excess 11-Oxygenated Androgens in Women With Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling.. 107. 2022
Epidural Steroid Injections Acutely Suppress Bone Formation Markers in Postmenopausal Women.. 107. 2022
Bariatric Surgery-induced High-density Lipoprotein Functionality Enhancement Is Associated With Reduced Inflammation. 2022
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.. 107. 2022
Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.. 107. 2022
Biochemical Markers of Bone Turnover in Older Adults with Type 1 Diabetes. 2022
Variations in Sleep Characteristics and Glucose Regulation in Young Adults With Type 1 Diabetes.. 107. 2022
Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes.. 106. 2021
Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study.. 106. 2021
MRI-based Texture Analysis of Trabecular Bone for Opportunistic Screening of Skeletal Fragility.. 106. 2021
Human Milk Hormone Intake in the First Month of Life and Physical Growth Outcomes in Preterm Infants.. 106. 2021
Vitamin D3 Dose Requirement that Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly. 2021
Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health.. 106. 2021
A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population.. 106. 2021
Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.. 106. 2021
Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.. 106. 2021
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.. 105. 2020
Comorbid Conditions and GFR Predict Nonvertebral Fractures in Patients With Diabetes in an Ethnic-Specific Manner.. 105. 2020
Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.. 105. 2020
Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.. 105. 2020
Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.. 105. 2020
Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.. 105. 2020
Kinome Profiling Reveals Abnormal Activity of Kinases in Skeletal Muscle From Adults With Obesity and Insulin Resistance.. 105. 2020
Diabetes-Related Fracture Risk Is Different in African Americans Compared With Hispanics and Caucasians.. 104. 2019
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.. 104. 2019
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.. 104. 2019
Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.. 103. 2018
Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes.. 103. 2018
Lower Spine Volumetric Bone Density in Patients With a History of Epidural Steroid Injections.. 103. 2018
Comprehensive Metabolic Profiling Reveals a Lipid-Rich Fingerprint of Free Thyroxine Far Beyond Classic Parameters.. 103. 2018
Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes.. 103. 2018
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.. 103. 2018
Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.. 102. 2017
The Association Between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.. 102. 2017
Constitutive Activation of AKT2 in Humans Leads to Hypoglycemia Without Fatty Liver or Metabolic Dyslipidemia.. 102. 2017
Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers.. 102. 2017
Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.. 102. 2017
Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.. 102. 2017
Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort.. 102. 2017
Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.. 102. 2017
Metabolic Fingerprints of Circulating IGF-1 and the IGF-1/IGFBP-3 Ratio: A Multifluid Metabolomics Study.. 101. 2016
Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.. 101. 2016
Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.. 101. 2016
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.. 101. 2016
Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.. 101. 2016
Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.. 101. 2016
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.. 101. 2016
Effect of Teriparatide on Bone Formation in the Human Femoral Neck.. 101. 2016
Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates.. 101. 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.. 101. 2016
FSH Levels Predict Bone Loss in Premenopausal Women Treated for Breast Cancer More Than One Year After Treatment.. 101. 2016
Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism.. 101. 2016
Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.. 100. 2015
High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.. 100. 2015
PRIDE Statement on the Need for a Moratorium on the CMS Plan to Cite Hospitals for Performing Point-of-Care Capillary Blood Glucose Monitoring on Critically Ill Patients.. 100. 2015
Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism.. 100. 2015
Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.. 100. 2015
Abnormal Skeletal Strength and Microarchitecture in Women With Celiac Disease.. 100. 2015
Arterialized venous bicarbonate is associated with lower bone mineral density and an increased rate of bone loss in older men and women.. 100. 2015
Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow-up ultrasound evaluation.. 100. 2015
Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids.. 99. 2014
Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancer.. 99. 2014
Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.. 99. 2014
Hypoxemia and glycemic control in type 2 diabetes mellitus with extreme obesity.. 99. 2014
Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy.. 99. 2014
Denosumab for treatment of hypercalcemia of malignancy.. 99. 2014
Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea.. 99. 2014
Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.. 99. 2014
Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.. 99. 2014
Outcomes in patients with poorly differentiated thyroid carcinoma.. 99. 2014
1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control.. 99. 2014
Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.. 99. 2013
Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.. 99. 2013
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.. 98. 2013
Pancreatic β-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity.. 98. 2013
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.. 98. 2013
Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression.. 98. 2013
Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer.. 98. 2013
Two novel functional single nucleotide polymorphisms of ADRB3 are associated with type 2 diabetes in the Chinese population.. 98. 2013
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.. 98. 2013
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.. 98. 2013
Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.. 98. 2013
Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.. 98. 2013
Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study.. 98. 2013
Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.. 98. 2013
Bariatric surgery results in cortical bone loss.. 98. 2013
Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism.. 98. 2013
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.. 98. 2012
Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.. 97. 2012
Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history.. 97. 2012
Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures.. 97. 2012
Differences in risk factors for coronary heart disease among diabetic and nondiabetic individuals from a population with high rates of diabetes: the Strong Heart Study.. 97. 2012
Increased marrow adiposity in premenopausal women with idiopathic osteoporosis.. 97. 2012
Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients.. 97. 2012
Skeletal-related events due to bone metastases from differentiated thyroid cancer.. 97. 2012
Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.. 97. 2012
Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation.. 97. 2011
Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus.. 96. 2011
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.. 96. 2011
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.. 96. 2011
Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.. 96. 2011
Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures.. 96. 2011
Final adult height in children with congenital adrenal hyperplasia treated with growth hormone.. 96. 2011
Adiposity, inflammation, and risk for death in black and white men and women in the United States: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.. 96. 2011
A dual sugar challenge test for lipogenic sensitivity to dietary fructose.. 96. 2011
Aberrations in pseudoautosomal regions (PARs) found in infertile men with Y-chromosome microdeletions.. 96. 2011
Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees.. 96. 2011
Hyperadiponectinemia is independent of kidney function, diabetes duration, and control in type 1 diabetic patients without microangiopathy.. 96. 2010
Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.. 95. 2010
Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implant.. 95. 2010
Cardiac structure and diastolic function in mild primary hyperparathyroidism.. 95. 2010
Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.. 95. 2010
Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital.. 95. 2010
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.. 95. 2009
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.. 94. 2009
Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.. 94. 2009
Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.. 94. 2009
Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.. 94. 2009
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.. 94. 2009
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.. 93. 2008
Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.. 93. 2008
The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss.. 93. 2008
Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.. 93. 2008
BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines.. 93. 2008
Reduced bone mineral density is associated with breast arterial calcification.. 93. 2007
Gene expression in peripheral blood mononuclear cells from children with diabetes.. 92. 2007
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.. 92. 2007
Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells.. 92. 2007
Nectin-1 is a marker of thyroid cancer sensitivity to herpes oncolytic therapy.. 92. 2007
Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease.. 91. 2006
Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.. 91. 2006
Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes.. 91. 2006
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans.. 91. 2006
Acute ovarian failure in the childhood cancer survivor study.. 91. 2006
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.. 91. 2005
Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.. 90. 2005
Success of testicular sperm extraction [corrected] and intracytoplasmic sperm injection in men with Klinefelter syndrome.. 90. 2005
Phenotypic features associated with mutations in steroidogenic acute regulatory protein.. 90. 2005
Inflammatory cytokine and thrombin regulation of interleukin-8 and intercellular adhesion molecule-1 expression in first trimester human decidua.. 90. 2005
Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans.. 90. 2005
Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial.. 90. 2005
Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency.. 90. 2004
Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.. 89. 2004
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.. 89. 2004
Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects.. 90. 2004
Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.. 89. 2004
Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with o-linked analogs in female rats.. 89. 2004
Long-term growth hormone therapy in adulthood results in significant linear growth in siblings with a PROP-1 gene mutation.. 89. 2004
Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.. 89. 2004
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.. 89. 2004
Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.. 89. 2004
Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.. 89. 2004
Ret/PTC activation in benign and malignant thyroid tumors arising in a population exposed to low-dose external-beam irradiation in childhood.. 89. 2004
The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.. 89. 2004
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.. 89. 2004
Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women.. 88. 2003
A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.. 88. 2003
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.. 88. 2003
Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study.. 88. 2003
Neonates with symptomatic hyperinsulinemic hypoglycemia generate inappropriately low serum cortisol counterregulatory hormonal responses.. 88. 2003
Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes.. 88. 2003
Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma.. 88. 2003
Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors.. 88. 2003
Spontaneous hypoglycemia in childhood is accompanied by paradoxically low serum growth hormone and appropriate cortisol counterregulatory hormonal responses.. 88. 2003
Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism.. 88. 2003
The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells.. 88. 2003
A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3.. 88. 2003
Antisense hTERT inhibits thyroid cancer cell growth.. 88. 2003
BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.. 87. 2002
Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.. 87. 2002
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?. 87. 2002
Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.. 87. 2002
Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary.. 87. 2002
Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon.. 87. 2002
First trimester insulin resistance and subsequent preeclampsia: a prospective study.. 87. 2002
Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.. 87. 2002
Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.. 87. 2002
Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins.. 87. 2002
Cyclooxygenase-2 expression in thyroid nodules.. 87. 2002
Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary.. 86. 2001
Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.. 86. 2001
Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.. 86. 2001
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.. 86. 2001
Alterations in plasma transforming growth factor beta in normoalbuminuric type 1 and type 2 diabetic patients.. 85. 2000
Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study.. 85. 2000
Primary medical therapy of micro- and macroprolactinomas in men.. 85. 2000
A human pituitary tumor-derived folliculostellate cell line.. 85. 2000
Activin effects on neoplastic proliferation of human pituitary tumors.. 85. 2000
Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.. 85. 2000
The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults.. 85. 2000
Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas.. 84. 1999
Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.. 84. 1999
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.. 84. 1999
A novel mutation in the CAG triplet region of exon 1 of androgen receptor gene causes complete androgen insensitivity syndrome in a large kindred.. 84. 1999
Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients.. 84. 1999
Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro.. 84. 1999
Therapeutic controversy: Obesity--a modern-day epidemic.. 84. 1999
Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects.. 83. 1998
Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells.. 83. 1998
Differential effect of race on the axial and appendicular skeletons of children.. 83. 1998
Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.. 83. 1998
The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred.. 83. 1998
Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.. 82. 1997
Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine.. 82. 1997
Differential effect of gender on the sizes of the bones in the axial and appendicular skeletons.. 82. 1997
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.. 81. 1996
Insulin-like growth factor II (IGF-II) inhibits insulin-like growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with a potency similar to insulin-like growth factor I (IGF-I) and higher than insulin.. 81. 1996
Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release.. 81. 1996
Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies.. 81. 1996
Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1 (IGFBP-1) production in human granulosa cells.. 81. 1996
Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis.. 81. 1996
Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy.. 80. 1995
Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man.. 80. 1995
Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women.. 80. 1995
A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone.. 80. 1995
Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.. 79. 1994
Chromosomal localization of the parathyroid hormone/parathyroid hormone-related protein receptor gene to human chromosome 3p21.1-p24.2.. 79. 1994
The relationship between serum levels of insulin and sex hormone-binding globulin in men: the effect of weight loss.. 79. 1994
Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency.. 79. 1994
Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy.. 79. 1994
Luteinizing hormone pulsatility in subjects with 5-alpha-reductase deficiency and decreased dihydrotestosterone production.. 78. 1994
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.. 78. 1994
Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.. 78. 1994
No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms.. 77. 1993
Aberrant deoxyribonucleic acid methylation in human thyroid tumors.. 77. 1993
Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line.. 77. 1993
The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.. 76. 1993
The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.. 76. 1993
The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.. 76. 1993
Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency.. 75. 1992
Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.. 75. 1992
Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.. 73. 1991
Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells.. 72. 1991
Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization.. 72. 1991
Brain glucose metabolism in noninsulin-dependent diabetes mellitus: a study in Pima Indians using positron emission tomography during hyperinsulinemia with euglycemic glucose clamp.. 71. 1990
Clonal origin of pituitary adenomas.. 71. 1990
Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity.. 71. 1990
H-ras protooncogene mutations in human thyroid neoplasms.. 71. 1990
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.. 70. 1990
Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.. 69. 1989
Radial and vertebral bone density in white and black women: evidence for racial differences in premenopausal bone homeostasis.. 69. 1989
Tissue levels of active and total renin, angiotensinogen, human chorionic gonadotropin, estradiol, and progesterone in human placentas from different methods of delivery.. 69. 1989
Hormonal manipulation of endometrial maturation.. 68. 1989
Regulation of insulin receptors in the human ovary: in vitro studies.. 67. 1988
Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH.. 67. 1988
Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.. 66. 1988
Prorenin secretion from human testis: no evidence for secretion of active renin or angiotensinogen.. 66. 1988
Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary.. 66. 1988
Effects of the antiglucocorticoid RU 486 on adrenal function in dogs.. 66. 1988
Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.. 65. 1987
Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle.. 65. 1987
Elevated levels of plasma prorenin (inactive renin) in diabetic and nondiabetic patients with autonomic dysfunction.. 64. 1987
Expression of the myc cellular proto-oncogene in human thyroid tissue.. 63. 1986
Regional distribution of human growth hormone-releasing hormone in the human hypothalamus by radioimmunoassay.. 62. 1986
Beta-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity.. 61. 1985
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.. 60. 1985
Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers.. 60. 1985
Anti-Müllerian hormone is not cytotoxic to human endometrial cancer in tissue culture.. 59. 1984
The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects.. 59. 1984
The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human.. 59. 1984
The thyrotropin (TSH) profile in isolated gonadotropin deficiency: a model to evaluate the effect of sex steroids on TSH secretion.. 57. 1983
Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites.. 56. 1983
Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.. 55. 1982
Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency.. 54. 1982
Opioid peptides in human plasma: evidence for multiple forms.. 54. 1982
Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men.. 54. 1982
Parathyroid imaging after intraarterial injections of [75Se]selenomethionine.. 52. 1981
In vitro inhibition of endometrial cancer growth by a neonatal rat testicular secretory product.. 52. 1981
Clomiphene attenuates the exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide occurring in primary testicular failure.. 52. 1981
Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy: report of 10 patients.. 52. 1981
The exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide in 1,2-dibromo-3-chloropropane-induced azoospermia.. 52. 1981
Acid-induced gastric inhibitory polypeptide secretion in man.. 51. 1980
Subnormal plasma adrenal androgen levels in men with uremia.. 51. 1980
Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence.. 51. 1980
Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults.. 51. 1980
Dissociation of prolactin response to thyrotropin-releasing hormone and metoclopramide in chronic renal failure.. 49. 1979
Impaired prolactin response to thyrotropin-releasing hormone in isolated gonadotropin deficiency and exaggerated response in primary testicular failure.. 48. 1979
Beta-adrenergically stimulated adenosine 3',5'-monophosphate accumulation in and parathyroid hormone release from dispersed human parathyroid cells.. 48. 1979
Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism.. 48. 1979
Human parathyroid autografts: comparison of function in vivo and in vitro.. 48. 1979
Urinary cAMP excretion during surgery: an index of successful parathyroidectomy in patients with primary hyperparathyroidism.. 47. 1978
Dispersed cells prepared from human parathyroid glands: distinct calcium sensitivity of adenomas vs. primary hyperplasia.. 46. 1978
Dissociation of prolactin responsiveness to TRH and chlorpromazine in women with isolated gonadotropin deficiency.. 45. 1977
Elevtion of serum testosterone in ovarian hyperstimulation syndrome.. 40. 1975
Isolated deficiency of follicle-stimulating hormone: Further studies.. 40. 1975
Effects of single and multiple pulses of arginine on insulin release in man.. 36. 1973
Development of anti-human FSH antibody in a patient with isolated FSH deficiency.. 36. 1973
Heterogeneity of gonadotropin response to LHRH in hypogonadotropic hypogonadism.. 36. 1973
Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.. 31. 1970
Induction of hepatic delta-amino-levulinic acid synthetase by oral contraceptive steroids.. 30. 1970
AGE AND ENZYME ACTIVITY IN THE HUMAN PINEAL.. 24. 1964
Impaired Bone Matrix: The Key to Fragility in Type 2 Diabetes? 2021
New Data to Challenge Gender-affirming Hormone Therapy Prescribing Practice. 2021
Is Better Sleep Beneficial for Metabolic Outcomes in Obese Female Adolescents with Polycystic Ovarian Syndrome? 2020
Regarding the consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. 2003
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. 2003
Metabolomics: A Promising Tool in the Prevention, Diagnosis, and Treatment of Obesity. 2024
Is it Time to Define Obesity by Body Composition and Not Solely Body Mass Index? 2024
Osteogenesis Imperfecta is more than a pediatric disorder - there is a need for adult care evidence to guide clinicians. 2023
Are Adrenal Androgens Altered by Gender-Affirming Hormone Therapy?. 108. 2023
"Insulin independence with SGLT2 inhibitor use in Type 2 Diabetes". 2023
Bariatric Surgery: It's Not Just Incretins!. 107. 2022
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.. 95. 2010
Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiation.. 89. 2004
Statins sentence thyroid cancer cells to death rho.. 88. 2003
Familial nonmedullary thyroid carcinoma--the case for genetic susceptibility.. 82. 1997
Depot somatostatin analogs--a new first line therapy for acromegaly.. 82. 1997
The History of the Follicular Variant of Papillary Thyroid Carcinoma. 2017
Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. 2015
Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase. 2012
Age- and race-based serum thyrotropin reference limits. 2009
On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. 2005
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. 2003
Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. 1998
Clinical review 87: In vitro fertilization for male factor infertility. 1997
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. 2022
Early Post-Renal Transplant Hyperglycemia. 2022
Long-Term Weight Loss Strategies for Obesity. 2021
Approach to the Patient with MODY-Monogenic Diabetes. 2021
Clinical review 156: Recombinant human thyrotropin and thyroid cancer management. 2003

VIVO Weill Cornell Medical College

The Journal of clinical endocrinology and metabolism Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)